Literature DB >> 2122029

Use of parenteral medium-chain triglyceride emulsion for maintaining seizure control in a 5-year-old girl with intractable diarrhea.

E Rosenthal1, B Weissman, K Kyllonen.   

Abstract

Medium-chain triglycerides (MCT) are an important component of an enteral ketogenic diet for seizure control. Previously, it was difficult to maintain ketosis when parenteral (iv) nutrition therapy was necessary. The use of iv MCT in a 5-year-old girl with Lennox-Gastaut syndrome who had diarrhea and dehydration is reported. Conventional 20% iv fat emulsion (long-chain triglycerides, LCT) and dextrose free hyperalimentation (HAL) in a 4:1 ketogenic ratio did not maintain adequate ketosis during bowel rest. Compassionate use of iv MCT (Clintec Nutrition) infused as a 70:30 MCT/LCT ratio plus HAL maintained moderate ketosis. Seizures were well controlled during the iv MCT regimen, which allowed normal daily functioning. Complications included abnormal liver function tests and severe iron deficiency anemia of unknown etiology. Serum triglyceride and cholesterol levels increased to 1717 mg/dl and 614 mg/dl, respectively, but decreased with a reduction of lipid infusion and use of an antihyperlipemic drug. Nutritional status was maintained. In this case, iv MCT proved to be a relatively safe and effective short-term method of continuing parenteral nutrition while maintaining ketosis for seizure control.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122029     DOI: 10.1177/0148607190014005543

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  2 in total

1.  Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide.

Authors:  Elles van der Louw; Vanessa Aldaz; Jessica Harvey; Marian Roan; Dorine van den Hurk; J Helen Cross; Stéphane Auvin
Journal:  Dev Med Child Neurol       Date:  2019-07-16       Impact factor: 5.449

2.  Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy.

Authors:  Anastasia Dressler; Nadja Haiden; Petra Trimmel-Schwahofer; Franz Benninger; Sharon Samueli; Gudrun Gröppel; Sina Spatzierer; Angelika Mühlebner; Klaus Abraham; Martha Feucht
Journal:  Epilepsia Open       Date:  2017-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.